Purpose: To assess the added prognostic value of the morphologic characteristics of intracranial arteries in the risk modeling of a future non-cardioembolic stroke. Materials and Methods: This retrospective study included 86 patients without acute ischemic stroke who first underwent magnetic resonance imaging (MRI) including the time-of-flight magnetic resonance angiography (TOF-MRA) at 3T. Diffusion-weighted imaging (DWI) was performed for the follow-up imaging of these patients > 120 days after the initial MRI. The TOF-MRA result was used to analyze three morphological characteristics: dilatation, stenosis, and tortuosity. The presence of acute ischemic stroke was assessed using the follow-up DWI data. We built two prognostic models: model 1 includes the conventional stroke-risk factors, while model 2 includes the conventional risk factors and the morphologic characteristics of the intracranial arteries. We used the likelihood-ratio test to compare these two models. The models' performances were evaluated using Harrell's concordance index. Results: Fourteen patients suffered non-cardioembolic strokes. The performances of the two models differed significantly regarding the future-risk modeling of the noncardioembolic stroke (p = 0.031). The Harrell's concordance index of model 2 (0.78 ± 0.05) exceeded that of model 1 (0.72 ± 0.07). Conclusion: In addition to the conventional stroke-risk factors, the morphologic characteristics of the intracranial arteries were useful in the modeling of the future risk of the non-cardioembolic ischemic stroke. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Time-of-flight magnetic resonance angiography (TOF-MRA) is one of the most commonly used magnetic resonance imaging (MRI) for assessing intracranial arterial disease. TOF-MRA is useful to detect and diagnose localized arterial disease, such as steno-occlusive lesions or aneurysms. In addition, given its relatively large field of view and high spatial resolution, TOF-MRA provides a general overview of the morphological characteristics of imaged vasculature (1, 2) . Information regarding morphological characteristic, such as tortuosity and dilatation, are well-known morphological characteristics of intracranial arteries (2) (3) (4) (5) (6) . Previous studies have suggested that these morphological characteristics are important imaging phenotypes that reflect the atherosclerotic changes and aging of intracranial arteries (1-3, 5, 7) .
Atherosclerotic changes in intracranial arteries are important causes of acute ischemic stroke. Therefore, previous studies have suggested that there is an association between the morphological characteristics of intracranial arteries and acute ischemic stroke (3, 4, 8, 9) . However, previous reports have only suggested that there is an association between them using cross The Added Prognostic Value of Intracranial Artery Morphology to Predict Non-Cardioembolic Ischemic Stroke 두개내 동맥의 형태학적 특성이 비심인성 색전 뇌경색 발생 위험에 미치는 추가적 예후 가치 jksronline.org J Korean Soc Radiol 2018;78(4):249-258 sectional studies (3, 4, (8) (9) (10) (11) . There has been limited assessment of causality. One study suggested the prognostic value of the morphological characteristics of the vasculature (12) . However, this study only focused on young patients with connective tissue disease; therefore, it is difficult to generalize their results to the general population. In this study, we evaluated the morphological characteristics of intracranial arteries using TOF-MRA at 3T. In a retrospective cohort, we then assessed the added prognostic value of the morphological characteristics of intracranial arteries to predict future ischemic stroke in addition to conventional stroke risk factors.
MATeRIAlS AND MeThODS

Study Population
We systemically reviewed our radiology database to create a retrospective cohort ( Fig. 1 ). We identified patients according to the following inclusion criteria: 1) patients who first underwent MRI, including TOF-MRA on 3T; 2) no acute ischemic stroke on initial MRI; 3) follow-up MRI with diffusion-weighted imaging (DWI); and 4) follow-up interval ≥ 120 days. We identified 29466 patients (41173 MRIs) who underwent brain MRI between January 2011 and September 2015. A total of 22774 patients were excluded because they underwent MRI without imaging follow-up and 2900 because they had MRI for brain neoplastic lesions, endovascular surgery, or epilepsy. Finally, we identified 3878 patients who underwent two or more MRI.
Among these patients, we excluded the following; 1) patients who underwent first MRI at 1.5T (n = 1284) because better image quality and spatial resolution of MRA at 3T than 1.5T, those were critical for diameter measurement and morphological evaluation; 2) patients who did not first undergo TOF-MRA (n = 882); 3) those without DWI on follow-up MRI (n = 264); and 4) those in whom the interval between the initial TOF-MRA and DWI was < 120 days (n = 1276). A total of 86 patients (40 males and 46 females, age 69.9 ± 10.9 years old) were included. This study was approved by the Institutional Review Board (KC15RI-SI0558). Informed consent was waived for this retrospective study. The reasons for first MRI was suspected stroke or transient ischemic attack (n = 27), headache (n = 26), dizziness or syncope (n = 17), known arterial stenosis (n = 5), regular follow-up after previous stroke (n = 7), others such as traumatic brain injury (n = 4). Reasons for second MRI was suspected stroke or transient ischemic attack (n = 49), headache (n = 3), dizziness or syncope (n = 28), known arterial stenosis (n = 2), others such as traumatic brain injury (n = 4).
We assessed the following patient characteristics from the medical records at the time of first MRI: 1) age; 2) sex; 3) hypertension; 4) type 2 diabetes; 5) dyslipidemia; 6) smoking history; 7) previous coronary artery disease; 8) previous ischemic stroke history; and 9) the degree of proximal internal carotid artery (ICA) stenosis. Hypertension was defined as systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg, or current treatment with antihypertensive drugs. Patients taking medications for diabetes (insulin or oral hypoglycemic) were considered to have diabetes mellitus. Dyslipidemia was diagnosed if the patient had any of the following: low-density lipoprotein cholesterol level ≥ 140 mg/dL, high-density lipoprotein cholesterol level ≤ 40 mg/dL, triglyceride level ≥ 150 mg/dL, or treatment with lipid-lowering medications (13) . Patients were considered to have a history of coronary artery disease if they had previous angina pectoris, myocardial infarction, or coronary artery bypass.
MRI Protocols
All initial MRIs were performed in a 3T machine (MAGNE- (Table 1) . These included dilatation, stenosis, and tortuosity. In order to assess intracranial artery dilatation, we measured the maximal diameter of the basilar artery (BA), and the terminal segments of both distal ICAs. The mean of these three maximal diameters were used as dilatation measurements of the intracranial arteries. The stenosis score was determined by the number of stenotic segments among seven pre-defined segments [terminal segments of both distal ICA, M1 segments of both middle cerebral artery (MCA), and the V4 segments of the vertebral artery (VA) and BA]. Stenotic segments were defined as those with ≥ 50% stenosis based on the Warfarin-Aspirin Symptomatic Intracranial Disease criteria (14) . Tortuosity was assessed in three segments of the intracranial arteries, including M1 segments of both MCA and BA, on a three-point scale. Zero indicates linear shape, 1 curved shape, and 2 sigmoid shape (1).
The summation of these three segment scores was used to calculate the tortuosity score. The other four segments (terminal segments of both distal ICA and V4 segments of the VA) were not evaluated for tortuosity given their natural tortuosity. (17, 18) .
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Statistical Analysis
To investigate the added value of the morphological characteristics of the intracranial arteries to future non-cardioembolic stroke risk, two prognostic models for future non-cardioembol-ic stroke were compared in order using the following method. 
ReSUlTS
Patient Characteristics
Twenty-four of 86 patients experienced acute ischemic stroke on follow-up DWI. Among them, fourteen patients had noncardioembolic strokes. Hypertension was more frequent in the patients in the stroke group (p = 0.012) than it was in the nonstroke group. The mean diameters were larger in patients with strokes than in those without stroke (p = 0.025). The clinical characteristics of the patient population according to the occurrence of ischemic stroke and its type are listed in Table 2 .
Univariate Analysis of Future Stroke Risk
Univariate analysis (Table 3 ) revealed that both the degree of ICA stenosis and the mean diameter of the intracranial arteries were significantly associated with future non-cardioembolic ischemic stroke risk (p < 0.05). Hypertension, previous territorial infarcts, the tortuosity score, and stenosis score were also marginally associated with future ischemic stroke (p < 0.2). For all ischemic strokes, the degree of ICA stenosis, history of coronary artery disease, and previous territorial infarction were significantly associated with future ischemic stroke risk. Hypertension, dyslipidemia, the mean diameter of the intracranial arteries, tortuosity score, and stenosis scores were marginally associated with future ischemic stroke (p < 0.2).
Multivariate Analysis of Future Stroke Risk
The multivariate analysis results are presented in Table 4 .
Among the three morphological characteristics, the mean diameter of the intracranial arteries was significantly associated with future non-cardioembolic strokes [hazard ratio (HR) 9.45, 95% confidence interval (CI) 1.41-63.55, p = 0.02] (Fig. 2) . The stenosis score was marginally associated with future non-cardio-embolic strokes (HR 2.26, 95% CI 0.84-6.07, p = 0.11). In contrast, tortuosity was not associated with future non-cardioembolic strokes (HR 0.97, 95% CI 0.57-1.63, p = 0.9).
The performance of models 1 (conventional risk factors only) and 2 (conventional risk factors and morphological findings) were significantly different with regard to modeling future noncardioembolic stroke risk (p = 0.031). Harrell's C-index of model 2 (0.75, 95% CI 0.571-0.929) was higher than that of model 1 (0.678, 95% CI 0.467-0.889). In contrast, models 1 and 2 did not differ in modeling the future risk of all ischemic strokes (p = 0.367). The C-index of model 1 (0.717, 95% CI 0.560-0.874) was similar to that of model 2 (0.736, 95% CI 0.587-0.885). We did not identify multicollinearity of the included variables in any of the models.
DISCUSSION
The association between imaging characteristics of the intracranial arteries, atherosclerotic changes and aging has been previously reported. The presence of a stenotic segment is a wellknown manifestation of atherosclerotic changes (1, 19, 20) .
Furthermore, tortuous and dilated intracranial arteries, aging and hypertension have also been reported as important atherosclerosis risk factors (3, 5, 7, 21) . We investigated three morphological characteristics of the intracranial arteries. Our result suggested that three morphological characteristics of intracranial arteries may be imaging phenotypes and surrogates for atherosclerotic changes. We think that the prognostic value of a high burden of intracranial atherosclerotic changes may be associat- ed with future non-cardioembolic stroke. An interesting finding is that the dilatation of intracranial artery was more important than other morphologic characteristics, including stenosis or tortuosity. One study suggested that the non-stenotic intracranial arteries of patients with acute ischemic stroke patients showed the tendency of positive remodeling (11) . Also, increased intracranial arterial diameter was suggested as a possible marker of chronic vascular insufficiency of the brain and was associated with vascular risk factors (3, 4) .
In our study, the imaging surrogates of intracranial atherosclerosis had added value for future non-cardioembolic stroke risk modeling. Because there is an association between the morphological characteristics of intracranial arteries and some stroke risk factors, one might argue that there was a multicollinearity effect between the risk factors and morphological characteristics. However, our results suggested the lack of multicollinearity between known stenotic risk factors and morphological characteristics.
In addition, the mean diameters of intracranial arteries were independently associated with future non-cardioembolic stroke in model 2. The lack of multicollinearity might be explained by the unique value of imaging surrogates (22) . There may be in- Acute ischemic stroke is a collection of heterogeneous diseases causing brain tissue ischemia. The Trial of ORG 10172 in Acute Stroke Treatment classification is one example that highlights the heterogeneous nature of ischemic stroke (23) . Cardioembolic stroke, which accounts for approximately one in four ischemic strokes, has a relatively different pathophysiology and treatment strategy than does other types of ischemic stroke (23) (24) (25) . Embolism from the heart to the brain results from one of the following mechanisms: structural heart abnormalities (e.g., left ventricular aneurysm), cardiac valvular disease, rightto-left shunts (paradoxical embolism), and rhythm disturbance (6) . Dilatation, tortuosity and stenotic segments of the intracranial arteries are associated with atherosclerotic changes. However, these characteristics were not closely linked to the mechanism of cardioembolic stroke. This finding explains why the morphological characteristics of intracranial arteries do not add value to the prediction of all types of ischemic stroke. One clinical study found that atrial fibrillation and the sudden onset of symptoms were independently associated with cardioembolic stroke; in contrast, hypertension, chronic obstructive pulmonary disease, diabetes mellitus, hyperlipidemia and age were all Survival curves of non-cardioembolic strokes according to three morphological characteristics. Three survival curves for non-cardioembolic stroke according to the intracranial arterial diameter (A), stenosis score (B) and tortuosity score (C). A mean intracranial arterial diameter > 3.1 was associated with significant risk for future noncardioembolic stroke (p < 0.001). Tortuous intracranial arteries were also associated with a tendency toward a high probability of future non-cardioembolic stroke (p = 0.158).
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In our study, hypertension was significantly more frequent in the non-cardioembolic stroke group than it was in the cardioembolic stroke group.
We performed a systematic, retrospective review to determine future stroke risk based on conventional ischemic stroke risk factors, in addition to the morphologies of intracranial arteries.
We found that the risk of future ischemic strokes is influenced by coronary artery disease, hypertension, stenosis of the proximal ICA, and imaging evidence of prior ischemic strokes. These findings are concordant with those of previous reports (27) (28) (29) .
This concordance also suggests that our retrospective cohort was relevant to assess future ischemic stroke risk. A history of coronary artery disease particularly increases the risk of future ischemic stroke, although it does not affect the risk of future noncardioembolic stroke.
In this study, we assessed the added prognostic value of the morphological characteristics of intracranial arteries to predict future ischemic stroke risk. When these morphological characteristics were combined with conventional risk factors, they were valuable in the prediction of future non-cardioembolic strokes. Among the three morphological characteristics that we included, the increased mean diameter or dilatation of the intracranial arteries was independently associated with future non-cardioembolic stroke risk. Stenosis of the intracranial arteries was also marginally associated with future risk of noncardioembolic stroke.
This study has several limitations. First, the sample size of included patients was relatively small. Fortunately, however, we reviewed a large number of patients systematically. The prognostic values of known ischemic stroke risk factors were concordant with a previous large-scale study. Small sample size and small number of event might limit the statistical power of the result. Future study with large subject is required to validate our result. Due to small size of population, subgroup analysis according to a variety of stroke etiology cannot be done. Second limitation is that our retrospective approach involved a degree of selection bias. Patients who visited another hospital for stroke episode cannot be included. Furthermore, we could not include other known risk factors, such as smoking, heart disease (other than coronary artery disease), alcohol consumption, or family history, because this information was not available in the medical records. Third limitation, which came using TOF-MRA, is that we could not detect some atherosclerotic changes.
Because TOF-MRA only visualizes the lumen of the vessel, atherosclerotic plaques with positive remodeling cannot be detected (10, 11) . Instead, we analyzed the diameter, degree of tortuosity and stenosis, all of which are well demonstrated on TOF-MRA. These characteristics are also associated with atherosclerotic changes. Additionally, the spatial resolution of the analyzed TOF-MRA might be not enough to quantify the degree of intracranial arterial stenosis, and measured value might be overestimating the true stenosis. Instead, we used the number of significantly stenotic segment, which might not be enough to represent the significance of stenosis degree of each segment. Although the number of stenotic segment showed marginal significance, future study is needed to validate this finding. Lastly, we used image-based definitions of acute ischemic stroke, rather than using medical records. Ischemic stroke was defined as only positive on DWI. Therefore, small lacunar infarcts or transient ischemic attack may have been missed. Also, because we defined stroke events based on diffusion-restriction lesion, we may miss subacute and chronic infarctions, or acute infarct patients those did not underwent DWI.
In conclusion, in combination with conventional stroke risk factors, assessment of the morphological characteristics of intracranial arteries adds value to predicting the risk of future non-cardioembolic ischemic stroke.
